Literature DB >> 12853505

Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects.

Yvonne F Heijdra1, Victor Pinto-Plata, Regina Frants, John Rassulo, Lawrence Kenney, Bartolome R Celli.   

Abstract

STUDY
OBJECTIVE: This study was designed to investigate the extent of clinical muscle dysfunction in stable patients with COPD who were attending an out-patient pulmonary clinic compared with that of age-matched control subjects without COPD. DESIGN AND
SUBJECTS: Respiratory muscle and hand grip strength, steady-state O(2) kinetics, and body composition were measured in 32 patients with COPD (19 women) [mean (+/- SD) FEV(1), 38 +/- 11% predicted] and 36 age-matched control subjects (13 women).
RESULTS: Measurements of handgrip force (mean, 97 +/- 32% vs 106 +/- 26% predicted, respectively), maximal expiratory pressure (mean, 57 +/- 33% vs 61 +/- 22% predicted, respectively), steady-state O(2) kinetics (mean tau, 72 +/- 34 s vs 78 +/- 37 s, respectively) and steady-state CO(2) kinetics (mean tau, 77 +/- 38 s vs 65 +/- 32 s, respectively) at submaximal exercise were similar in patients and control subjects. All the subjects, except for one female COPD patient, had a normal fat-free mass index (FFMI), although on average the FFMI was lower in male patients (19.8 +/- 2.8) than in male control subjects (23.0 +/- 2.8; p < 0.01).
CONCLUSIONS: In patients with COPD who were attending a regular outpatient pulmonary clinic, there was no evidence of reduced upper extremity and expiratory muscle strength or prolonged O(2) and CO(2) kinetics during isowork submaximal cardiopulmonary exercise compared to healthy, age-matched control subjects. Also, a normal body composition was found in nearly all COPD patients. This argues against the existence of a clinically significant systemic myopathy in most stable patients with severe COPD and normal FFMI.

Entities:  

Mesh:

Year:  2003        PMID: 12853505     DOI: 10.1378/chest.124.1.75

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

2.  Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.

Authors:  W D-C Man; N S Hopkinson; F Harraf; D Nikoletou; M I Polkey; J Moxham
Journal:  Thorax       Date:  2005-05-27       Impact factor: 9.139

3.  Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.

Authors:  S Yende; G W Waterer; E A Tolley; A B Newman; D C Bauer; D R Taaffe; R Jensen; R Crapo; S Rubin; M Nevitt; E M Simonsick; S Satterfield; T Harris; S B Kritchevsky
Journal:  Thorax       Date:  2005-11-11       Impact factor: 9.139

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

5.  Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score.

Authors:  Nitin Mehrotra; Amado X Freire; Douglas C Bauer; Tamara B Harris; Anne B Newman; Stephen B Kritchevsky; Bernd Meibohm
Journal:  Ann Epidemiol       Date:  2010-03       Impact factor: 3.797

6.  Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease.

Authors:  F de Blasio; M G Santaniello; F de Blasio; G Mazzarella; A Bianco; L Lionetti; F M E Franssen; L Scalfi
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

7.  Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?

Authors:  Eulogio Pleguezuelos; Cristina Esquinas; Eva Moreno; Lluis Guirao; Javier Ortiz; Joan Garcia-Alsina; Alex Merí; Marc Miravitlles
Journal:  Lung       Date:  2016-01-07       Impact factor: 2.584

Review 8.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification.

Authors:  Tewe L Verhage; Yvonne F Heijdra; Johan Molema; Leonie Daudey; P N Richard Dekhuijzen; Jan H Vercoulen
Journal:  Open Respir Med J       Date:  2009-02-13

10.  Upper limb muscle strength & endurance in chronic obstructive pulmonary disease.

Authors:  Swati Shah; Pradeep Nahar; Savita Vaidya; Sundeep Salvi
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.